Standard
Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA. / Foged, Camilla (Inventor); Franzyk, Henrik (Inventor); Zeng, Xianghui (Inventor); Nielsen, Hanne Mørck (Inventor); Thanki, Kaushik (Inventor).
Patent No.: WO2017158093-A1. Sep 21, 2017.
Research output: Patent
Harvard
Foged, C, Franzyk, H, Zeng, X
, Nielsen, HM & Thanki, K Sep. 21 2017,
Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA, Patent No. WO2017158093-A1. <
https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20170921&CC=WO&NR=2017158093A1&KC=A1>
APA
Foged, C., Franzyk, H., Zeng, X.
, Nielsen, H. M., & Thanki, K. (2017).
Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA. (Patent No.
WO2017158093-A1).
https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20170921&CC=WO&NR=2017158093A1&KC=A1
Vancouver
Foged C, Franzyk H, Zeng X, Nielsen HM, Thanki K, inventors. Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA. WO2017158093-A1. 2017 Sep 21.
Author
Foged, Camilla (Inventor) ; Franzyk, Henrik (Inventor) ; Zeng, Xianghui (Inventor) ; Nielsen, Hanne Mørck (Inventor) ; Thanki, Kaushik (Inventor). / Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA. Patent No.: WO2017158093-A1. Sep 21, 2017.
Bibtex
@misc{11f632b0756f452cae5ffe0a0a05570b,
title = "Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA",
abstract = "The present invention relates to a nanoparticle compn. comprising PLGA derivs. and a lipid. The compn. is suitable for medical use. Particularly, the present invention relates to a delivery system for delivery of drugs, in particular nucleic acids, with enhanced efficacy and reduced adverse effects, such as reduced toxicity and immunogenicity, on healthy tissue. More precisely, the present invention relates to a delivery system comprising hybrid nanoparticles comprising PLGA and lipidoids for the delivery of siRNA.",
author = "Camilla Foged and Henrik Franzyk and Xianghui Zeng and Nielsen, {Hanne M{\o}rck} and Kaushik Thanki",
year = "2017",
month = sep,
day = "21",
language = "English",
type = "Patent",
note = "WO2017158093-A1; A61K31/713,A61K47/18,A61K47/34,A61K9/51,A61P25/00,A61P29/00,A61P35/00",
}
RIS
TY - PAT
T1 - Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA
AU - Foged, Camilla
AU - Franzyk, Henrik
AU - Zeng, Xianghui
AU - Nielsen, Hanne Mørck
AU - Thanki, Kaushik
PY - 2017/9/21
Y1 - 2017/9/21
N2 - The present invention relates to a nanoparticle compn. comprising PLGA derivs. and a lipid. The compn. is suitable for medical use. Particularly, the present invention relates to a delivery system for delivery of drugs, in particular nucleic acids, with enhanced efficacy and reduced adverse effects, such as reduced toxicity and immunogenicity, on healthy tissue. More precisely, the present invention relates to a delivery system comprising hybrid nanoparticles comprising PLGA and lipidoids for the delivery of siRNA.
AB - The present invention relates to a nanoparticle compn. comprising PLGA derivs. and a lipid. The compn. is suitable for medical use. Particularly, the present invention relates to a delivery system for delivery of drugs, in particular nucleic acids, with enhanced efficacy and reduced adverse effects, such as reduced toxicity and immunogenicity, on healthy tissue. More precisely, the present invention relates to a delivery system comprising hybrid nanoparticles comprising PLGA and lipidoids for the delivery of siRNA.
M3 - Patent
M1 - WO2017158093-A1
Y2 - 2017/03/16
ER -
